FE 999302

· Ferring Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for FE 999302, covering 2023-08-31 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation [Phase 1]

See pricing